Gregory G. Burrows
Nessuna posizione attualmente
Profilo
Gregory G.
Burrows is the founder of Artielle ImmunoTherapeutics, Inc. which was founded in 2004.
He held the title of Scientist at the company.
Burrows received his undergraduate degree from Clark University and his doctorate degree from Washington State University.
Precedenti posizioni note di Gregory G. Burrows
| Società | Posizione | Fine |
|---|---|---|
Artielle ImmunoTherapeutics, Inc.
 Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Fondatore | 18/11/2014 |
Formazione di Gregory G. Burrows
| Clark University | Undergraduate Degree |
| Washington State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Health Technology |
- Borsa valori
- Insiders
- Gregory G. Burrows
